In patients that are phenotypically suspicious for HHT but test negative for a variant in HHT genes (ENG, ACVRL1/ALK1, or SMAD4), consideration of a pathogenic EPHB4 variant is crucial. This evidence concerns the gene SMAD4 and hereditary hemorrhagic telangiectasia.